Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for ...
Atazanavir can cause serious, life-threatening side effects. These include heart rhythm problems, severe rash, liver problems, and life-threatening drug ...
Several FDA-approved drug labels may be available for atazanavir. AIDSinfo provides the following drug label solely as an example of the labels available for ...
Atazanavir (Reyataz) is an antiretroviral drug from the class known as protease inhibitors. Protease inhibitors block the activity of the HIV protease (or ...
Nov 15, 2016 ... Atazanavir: learn about side effects, dosage, special precautions, and more on MedlinePlus.
Medscape - HIV infection dosing for Reyataz (atazanavir), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...
Jun 23, 2003 ... Approval. Atazanavir was approved by the FDA in June 2003 for use in combination with other antiretroviral agents in adults with HIV infection.
Find patient medical information for Atazanavir Oral on WebMD including its uses , side effects and safety, interactions, pictures, warnings and user ratings.
Easy to read patient leaflet for Atazanavir. Includes indications, proper use, special instructions, precautions, and possible side effects.